About Decipher Labs
Decipher Labs is a publicly listed company based in Hyderabad (India) founded in 1986. Healthcare company that develops and commercializes genomic tests for personalized cancer treatment, focusing on prostate and bladder cancer diagnosis and treatment planning. Its Indian entity Decipher Labs Limited reported revenue of ₹14.27 Cr. Decipher Labs offers products and services including Branded Formulations, ERP Implementation, and Mobile and Cloud Solutions. Its focus areas include Biopharma Outsourcing and Diversified.
Company details
Decipher Labs was founded in 1986 in Hyderabad, India, as a healthcare company in the genomics sector. Genomic testing solutions are offered for patients with prostate and bladder cancer. RNA biomarkers are utilized in these tests to classify tumors and support physicians in determining treatment options. Operations focus on enabling informed decisions between patients and healthcare providers, with services centered on diagnosis and planning in the Indian market.
- Headquarters Hyderabad, India
- Stage Public
- SectorsHealthcare
- Website decipherlabs.in
- Legal Name Decipher Labs Ltd.
- Market Cap₹5.13 Cr
DECIPHER · BSE
- Share Price₹5.20
+2.36% today
- Revenue₹14.05 Cr
FY 2025-26 · -37.9% YoY
- EBITDA−₹3.39 Cr
Margin -24.1%
- Net Profit−₹3.09 Cr
FY 2025-26 · -1288.5% YoY
Associated legal entities of Decipher Labs
Decipher Labs operates through Decipher Labs Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Decipher Labs Limited Listed CIN L24230TG1986PLC006781 | Active | 17 Sep 1986 | Hyderabad, Telangana | ₹14.3 Cr | 5 | 7 | View details |
Products & Services of Decipher Labs
Decipher Labs offers a comprehensive portfolio of products and services, including Branded Formulations, ERP Implementation, and Mobile and Cloud Solutions.
Manufactured pharmaceutical products for marketing and supply
Services for implementing ERP systems and solutions
Development of mobile and cloud-based IT products
Board of directors of Decipher Labs Limited (Decipher Labs)
Decipher Labs Limited is the primary company behind Decipher Labs. The board of Decipher Labs Limited currently have 6 directors; the longest-serving is Sushant Mohan Lal, appointed in 2006. 15 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sushant Mohan Lal DIN 01227151 | Director | 19 May 2006 | 20 yrs 5 mo | Decipher Labs Limited |
| Venkateswara Rao Gudipudi DIN 02147615 | Director | 13 Aug 2022 | 4 yrs 2 mo | Decipher Labs Limited |
| Lakshmi Vijaya Nimmala DIN 09788849 | Director | 14 Feb 2023 | 3 yrs 8 mo | Decipher Labs Limited |
| Janaki Ram Ajjarapu DIN 02155939 | Director | 14 Feb 2023 | 3 yrs 8 mo | Decipher Labs Limited |
| Gayathri Raghuram DIN 09775806 | Director | 04 Sep 2023 | 3 yrs 1 mo | Decipher Labs Limited |
| Dalavath Amar Singh DIN 02206249 | Whole-time director | 13 Nov 2025 | 11 mo | Decipher Labs Limited |
IPO & Listings of Decipher Labs
Decipher Labs is a publicly listed company on the BSE with ticker symbol DECIPHER in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date13 Feb 1995
- Listed onBSE: 524752
- Listed entityDecipher Labs Ltd.
- Exchange sectorHealth technology
- ISININE643N01012
- Share price₹6.09 (+12.36% on the day) · 2026-10-14
- Volume (last session)2,329
Financials of Decipher Labs
Exchange-reported figures of Decipher Labs Limited, the listed company behind Decipher Labs (BSE: DECIPHER).
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 14.05 | 22.61 | 35.88 | 45.57 | 65.32 | 55.56 | 23.99 |
| Revenue growth | -37.9% | -37.0% | -21.3% | -30.2% | +17.6% | +131.6% | - |
| EBITDA | (3.39) | (7.23) | (0.94) | (10.62) | 6.02 | 3.49 | 2.53 |
| EBITDA margin | -24.1% | -32.0% | -2.6% | -23.3% | +9.2% | +6.3% | +10.6% |
| Profit before tax | (3.69) | (6.39) | (1.21) | (4.16) | 12.34 | 2.15 | 1.47 |
| Net profit | (3.09) | 0.26 | (1.51) | 3.77 | 11.37 | 1.41 | 1.10 |
| Net profit margin | -22.0% | +1.2% | -4.2% | +8.3% | +17.4% | +2.5% | +4.6% |
| EPS (₹) | (3.05) | (5.03) | (1.66) | (2.66) | 11.27 | 1.39 | 1.09 |
| Balance sheet | |||||||
| Total assets | 21.17 | 23.10 | 21.86 | 24.16 | 34.49 | 30.08 | 23.84 |
| Net worth | 20.67 | 22.86 | 21.86 | 23.21 | 24.17 | 13.69 | 12.56 |
| Total debt | 0.50 | 0.24 | 0.00 | 0.95 | 10.32 | 16.39 | 11.28 |
| Cash & bank | 0.74 | 2.81 | 9.31 | 7.42 | 15.41 | 6.98 | 1.47 |
| Net working capital | 15.95 | 18.39 | 12.90 | 16.07 | 30.76 | 13.90 | 11.13 |
| Cash flow | |||||||
| Cash from operations | (2.45) | (9.82) | 4.85 | (1.56) | 8.26 | 1.83 | (15.18) |
| Cash from investing | (0.24) | 3.07 | (1.79) | (4.28) | (1.13) | (0.31) | (0.01) |
| Cash from financing | 0.00 | 0.24 | (1.17) | (2.15) | 1.30 | 3.99 | 16.36 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.41 | 3.60 | 3.21 | 4.31 | 2.92 | 3.50 | 5.80 | 5.87 |
| Revenue growth (YoY) | -17.5% | +2.9% | -44.7% | -26.6% | -60.8% | - | - | - |
| Other income | 0.10 | 0.17 | 0.02 | 0.02 | 0.01 | 0.87 | 0.17 | 0.12 |
| EBITDA | (2.16) | 0.22 | (0.43) | 0.12 | (3.32) | (6.58) | (0.64) | (1.33) |
| EBITDA margin | -89.6% | +6.1% | -13.4% | +2.8% | -113.7% | -188.0% | -11.0% | -22.7% |
| Depreciation | 0.13 | 0.15 | 0.13 | 0.13 | 0.12 | 0.13 | 0.12 | 0.12 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (2.19) | 0.24 | (0.54) | 0.01 | (3.43) | (5.84) | (0.59) | (1.33) |
| Tax | 0.00 | 0.61 | 0.01 | 0.00 | 0.00 | (1.73) | 0.01 | 0.00 |
| Net profit | (2.19) | (0.37) | (0.55) | 0.01 | (3.43) | (4.11) | (0.60) | (1.33) |
| EPS (₹) | (2.16) | (0.35) | (0.53) | 0.02 | (3.39) | (4.07) | (0.59) | (1.31) |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 1.14 | 0.85 | 3.53 | 0.81 | 0.99 | 0.98 | 1.42 |
| Revenue growth | +34.1% | -75.9% | +335.8% | -18.2% | +1.0% | -31.0% | - |
| EBITDA | (0.22) | (0.45) | 0.02 | (2.60) | 0.36 | 0.03 | 0.16 |
| EBITDA margin | -19.3% | -52.9% | +0.6% | -321.0% | +36.4% | +3.1% | +11.3% |
| Profit before tax | (0.24) | (0.45) | 0.03 | (2.63) | 0.36 | 0.11 | 0.17 |
| Net profit | (0.25) | (0.45) | 0.03 | (0.30) | 0.36 | 0.11 | 0.17 |
| Net profit margin | -21.9% | -52.9% | +0.9% | -37.0% | +36.4% | +11.2% | +12.0% |
| EPS (₹) | (0.24) | (0.44) | 0.02 | (2.59) | 0.36 | 0.10 | 0.17 |
| Balance sheet | |||||||
| Total assets | 8.74 | 8.73 | 8.93 | 8.90 | 11.52 | 11.30 | 11.30 |
| Net worth | 8.24 | 8.49 | 8.93 | 8.90 | 11.52 | 11.16 | 11.07 |
| Total debt | 0.50 | 0.24 | 0.00 | 0.00 | 0.00 | 0.14 | 0.23 |
| Cash & bank | 0.03 | 0.05 | 0.03 | 0.06 | 0.05 | 0.02 | 0.03 |
| Net working capital | (0.09) | (0.13) | 0.15 | 0.10 | 2.52 | 2.62 | 2.77 |
| Cash flow | |||||||
| Cash from operations | (0.29) | (0.17) | (0.03) | (0.08) | 0.55 | 0.27 | (0.01) |
| Cash from investing | 0.00 | (0.05) | 0.00 | 0.09 | (0.38) | (0.19) | (0.07) |
| Cash from financing | 0.26 | 0.24 | 0.00 | 0.00 | (0.14) | (0.09) | 0.09 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.10 | 0.07 | 0.13 | 0.09 | 0.85 | 0.23 | 0.16 | 0.08 |
| Revenue growth (YoY) | -88.2% | -69.6% | -18.8% | +12.5% | +123.7% | - | - | - |
| Other income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Total expenses | 0.17 | 0.24 | 0.14 | 0.20 | 0.78 | 0.39 | 0.25 | 0.15 |
| EBITDA | (0.07) | (0.17) | (0.01) | (0.11) | 0.07 | (0.16) | (0.09) | (0.07) |
| EBITDA margin | -70.0% | -242.9% | -7.7% | -122.2% | +8.2% | -69.6% | -56.3% | -87.5% |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (0.07) | (0.17) | (0.01) | (0.11) | 0.07 | (0.16) | (0.09) | (0.05) |
| Tax | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.41 | 3.60 | 3.21 | 4.31 | 2.92 | 3.50 | 5.80 | 5.87 |
| Revenue growth (YoY) | -17.5% | +2.9% | -44.7% | -26.6% | -60.8% | - | - | - |
| Other income | 0.10 | 0.17 | 0.02 | 0.02 | 0.01 | 0.87 | 0.17 | 0.12 |
| EBITDA | (2.16) | 0.22 | (0.43) | 0.12 | (3.32) | (6.58) | (0.64) | (1.33) |
| EBITDA margin | -89.6% | +6.1% | -13.4% | +2.8% | -113.7% | -188.0% | -11.0% | -22.7% |
| Depreciation | 0.13 | 0.15 | 0.13 | 0.13 | 0.12 | 0.13 | 0.12 | 0.12 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (2.19) | 0.24 | (0.54) | 0.01 | (3.43) | (5.84) | (0.59) | (1.33) |
| Tax | 0.00 | 0.61 | 0.01 | 0.00 | 0.00 | (1.73) | 0.01 | 0.00 |
| Net profit | (2.19) | (0.37) | (0.55) | 0.01 | (3.43) | (4.11) | (0.60) | (1.33) |
| EPS (₹) | (2.16) | (0.35) | (0.53) | 0.02 | (3.39) | (4.07) | (0.59) | (1.31) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 14.05 | 22.61 | 35.88 | 45.57 | 65.32 | 55.56 | 23.99 |
| Revenue growth | -37.9% | -37.0% | -21.3% | -30.2% | +17.6% | +131.6% | - |
| Other income | 0.22 | 1.32 | 0.42 | 7.37 | 7.67 | 0.65 | 0.27 |
| Total expenses | 17.44 | 29.84 | 36.82 | 56.19 | 59.30 | 52.07 | 21.46 |
| Employee cost | 0.00 | 21.32 | 27.75 | 41.16 | 47.46 | 47.34 | 19.32 |
| EBITDA | (3.39) | (7.23) | (0.94) | (10.62) | 6.02 | 3.49 | 2.53 |
| EBITDA margin | -24.1% | -32.0% | -2.6% | -23.3% | +9.2% | +6.3% | +10.6% |
| Depreciation | 0.52 | 0.48 | 0.45 | 0.43 | 0.87 | 0.82 | 0.56 |
| Interest | 0.00 | 0.00 | 0.24 | 0.48 | 0.48 | 1.17 | 0.77 |
| Profit before tax | (3.69) | (6.39) | (1.21) | (4.16) | 12.34 | 2.15 | 1.47 |
| Tax | (0.60) | (1.31) | 0.46 | (1.48) | 0.97 | 0.74 | 0.37 |
| Net profit | (3.09) | 0.26 | (1.51) | 3.77 | 11.37 | 1.41 | 1.10 |
| Net profit margin | -22.0% | +1.2% | -4.2% | +8.3% | +17.4% | +2.5% | +4.6% |
| EPS (₹) | (3.05) | (5.03) | (1.66) | (2.66) | 11.27 | 1.39 | 1.09 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 10.10 | 10.10 | 10.10 | 10.10 | 10.10 | 10.10 | 10.10 |
| Reserves & surplus | 10.57 | 12.76 | 11.76 | 13.11 | 14.07 | 3.59 | 2.46 |
| Shareholders' funds (net worth) | 20.67 | 22.86 | 21.86 | 23.21 | 24.17 | 13.69 | 12.56 |
| Minority interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 0.50 | 0.24 | 0.00 | 0.95 | 10.32 | 16.39 | 11.28 |
| Total debt | 0.50 | 0.24 | 0.00 | 0.95 | 10.32 | 16.39 | 11.28 |
| Total liabilities | 21.17 | 23.10 | 21.86 | 24.16 | 34.49 | 30.08 | 23.84 |
| Assets | |||||||
| Gross block | 2.72 | 2.89 | 3.14 | 3.46 | 2.92 | 4.51 | 4.99 |
| Net block | 2.26 | 2.55 | 2.91 | 3.32 | 2.83 | 4.44 | 4.98 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.26 | 0.26 | 3.39 | 3.76 | 0.26 | 0.00 | 0.00 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.04 | 0.32 |
| Sundry debtors | 2.60 | 4.22 | 7.80 | 9.85 | 12.79 | 11.67 | 14.62 |
| Cash & bank balances | 0.74 | 2.81 | 9.31 | 7.42 | 15.41 | 6.98 | 1.47 |
| Loans & advances | 15.77 | 14.02 | 7.56 | 2.81 | 9.98 | 3.85 | 6.27 |
| Total current assets | 19.11 | 21.05 | 24.67 | 20.08 | 38.22 | 22.54 | 22.68 |
| Total current liabilities | 3.16 | 2.66 | 11.77 | 4.01 | 7.46 | 8.64 | 11.55 |
| Net working capital | 15.95 | 18.39 | 12.90 | 16.07 | 30.76 | 13.90 | 11.13 |
| Total assets | 21.17 | 23.10 | 21.86 | 24.16 | 34.49 | 30.08 | 23.84 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 2.81 | 9.31 | 7.42 | 15.41 | 6.98 | 1.47 | 0.30 |
| Net cash from operating activities | (2.45) | (9.82) | 4.85 | (1.56) | 8.26 | 1.83 | (15.18) |
| Net cash from investing activities | (0.24) | 3.07 | (1.79) | (4.28) | (1.13) | (0.31) | (0.01) |
| Net cash from financing activities | 0.00 | 0.24 | (1.17) | (2.15) | 1.30 | 3.99 | 16.36 |
| Net change in cash | (2.69) | (6.51) | 1.90 | (7.99) | 8.43 | 5.51 | 1.17 |
| Closing cash | 0.74 | 2.81 | 9.31 | 7.42 | 15.41 | 6.98 | 1.47 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -37.9% | -37.0% | -21.3% | -30.2% | +17.6% | +131.6% | - |
| EBITDA growth | +53.1% | -669.2% | +91.2% | -276.4% | +72.5% | +37.9% | - |
| PBT growth | +42.3% | -428.1% | +70.9% | - | +474.0% | +46.3% | +241.9% |
| Net income growth | -1288.5% | +117.2% | -140.1% | -66.8% | +706.4% | +28.2% | - |
| Revenue CAGR (3Y) | -32.4% | -29.8% | -13.6% | +23.9% | +100.9% | +279.1% | - |
| EBITDA CAGR (3Y) | -31.7% | - | - | - | +139.2% | +252.0% | - |
| Profitability & leverage | |||||||
| Net income margin | -22.0% | -22.5% | -4.7% | -5.9% | +17.4% | +2.5% | +4.6% |
| Return on capital employed | - | -4.7% | -3.1% | +9.5% | +38.0% | +10.8% | +12.3% |
| Return on net worth | - | +1.2% | -6.8% | +15.9% | +55.8% | +8.4% | +8.8% |
| Debt / equity | - | 0.01 | 0.02 | 0.24 | 0.71 | 1.05 | 0.76 |
| Long-term debt / equity | - | 0.00 | 0.00 | 0.14 | 0.38 | 0.35 | 0.10 |
| Interest cover | 0.00 | 0.00 | -17.27 | -4.34 | 9.32 | 43.82 | 39.09 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 7.50 | 10.87 | 14.29 | 17.58 | 11.70 | 9.60 |
| Inventory turnover | - | 0.00 | 0.00 | 2,278.50 | 1,633.00 | 308.67 | 74.97 |
| Debtors turnover | - | 3.76 | 4.07 | 4.03 | 5.34 | 4.23 | 2.65 |
| EPS (₹) | (3.05) | (5.03) | (1.66) | (2.66) | 11.27 | 1.39 | 1.09 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 22.63 | 21.64 | 22.98 | 23.93 | 13.55 | 12.44 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.10 | 0.07 | 0.13 | 0.09 | 0.85 | 0.23 | 0.16 | 0.08 |
| Revenue growth (YoY) | -88.2% | -69.6% | -18.8% | +12.5% | +123.7% | - | - | - |
| Other income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Total expenses | 0.17 | 0.24 | 0.14 | 0.20 | 0.78 | 0.39 | 0.25 | 0.15 |
| EBITDA | (0.07) | (0.17) | (0.01) | (0.11) | 0.07 | (0.16) | (0.09) | (0.07) |
| EBITDA margin | -70.0% | -242.9% | -7.7% | -122.2% | +8.2% | -69.6% | -56.3% | -87.5% |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (0.07) | (0.17) | (0.01) | (0.11) | 0.07 | (0.16) | (0.09) | (0.05) |
| Tax | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 1.14 | 0.85 | 3.53 | 0.81 | 0.99 | 0.98 | 1.42 |
| Revenue growth | +34.1% | -75.9% | +335.8% | -18.2% | +1.0% | -31.0% | - |
| Other income | 0.00 | 0.02 | 0.02 | 0.03 | 0.05 | 0.14 | 0.01 |
| Total expenses | 1.36 | 1.30 | 3.51 | 3.41 | 0.63 | 0.95 | 1.26 |
| Employee cost | 0.00 | 0.16 | 0.17 | 0.17 | 0.20 | 0.15 | 0.13 |
| EBITDA | (0.22) | (0.45) | 0.02 | (2.60) | 0.36 | 0.03 | 0.16 |
| EBITDA margin | -19.3% | -52.9% | +0.6% | -321.0% | +36.4% | +3.1% | +11.3% |
| Depreciation | 0.02 | 0.02 | 0.01 | 0.06 | 0.05 | 0.04 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
| Profit before tax | (0.24) | (0.45) | 0.03 | (2.63) | 0.36 | 0.11 | 0.17 |
| Tax | 0.01 | 0.00 | 0.00 | (0.02) | 0.00 | 0.00 | 0.00 |
| Net profit | (0.25) | (0.45) | 0.03 | (0.30) | 0.36 | 0.11 | 0.17 |
| Net profit margin | -21.9% | -52.9% | +0.9% | -37.0% | +36.4% | +11.2% | +12.0% |
| EPS (₹) | (0.24) | (0.44) | 0.02 | (2.59) | 0.36 | 0.10 | 0.17 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 10.10 | 10.10 | 10.10 | 10.10 | 10.10 | 10.10 | 10.10 |
| Reserves & surplus | (1.86) | (1.61) | (1.17) | (1.20) | 1.42 | 1.06 | 0.97 |
| Shareholders' funds (net worth) | 8.24 | 8.49 | 8.93 | 8.90 | 11.52 | 11.16 | 11.07 |
| Secured loans | 0.50 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 0.23 |
| Total debt | 0.50 | 0.24 | 0.00 | 0.00 | 0.00 | 0.14 | 0.23 |
| Total liabilities | 8.74 | 8.73 | 8.93 | 8.90 | 11.52 | 11.30 | 11.30 |
| Assets | |||||||
| Gross block | 0.29 | 0.29 | 0.24 | 0.24 | 0.43 | 0.30 | 0.11 |
| Net block | 0.12 | 0.13 | 0.10 | 0.12 | 0.34 | 0.26 | 0.11 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 8.66 | 8.66 | 8.66 | 8.66 | 8.66 | 8.41 | 8.41 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.04 | 0.32 |
| Sundry debtors | 0.03 | 0.23 | 3.95 | 0.13 | 0.22 | 0.41 | 0.17 |
| Cash & bank balances | 0.03 | 0.05 | 0.03 | 0.06 | 0.05 | 0.02 | 0.03 |
| Loans & advances | 0.10 | 0.04 | 0.00 | 0.00 | 2.29 | 2.25 | 2.60 |
| Total current assets | 0.16 | 0.32 | 3.98 | 0.19 | 2.60 | 2.72 | 3.12 |
| Total current liabilities | 0.25 | 0.45 | 3.83 | 0.09 | 0.08 | 0.10 | 0.35 |
| Net working capital | (0.09) | (0.13) | 0.15 | 0.10 | 2.52 | 2.62 | 2.77 |
| Total assets | 8.74 | 8.73 | 8.93 | 8.90 | 11.52 | 11.30 | 11.30 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.05 | 0.03 | 0.06 | 0.05 | 0.02 | 0.03 | 0.02 |
| Net cash from operating activities | (0.29) | (0.17) | (0.03) | (0.08) | 0.55 | 0.27 | (0.01) |
| Net cash from investing activities | 0.00 | (0.05) | 0.00 | 0.09 | (0.38) | (0.19) | (0.07) |
| Net cash from financing activities | 0.26 | 0.24 | 0.00 | 0.00 | (0.14) | (0.09) | 0.09 |
| Net change in cash | (0.03) | 0.03 | (0.03) | 0.01 | 0.03 | (0.01) | 0.01 |
| Closing cash | 0.03 | 0.05 | 0.03 | 0.06 | 0.05 | 0.02 | 0.03 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +34.1% | -75.9% | +335.8% | -18.2% | +1.0% | -31.0% | - |
| EBITDA growth | +51.1% | -2350.0% | +100.8% | -822.2% | +1100.0% | -81.3% | - |
| PBT growth | +46.7% | - | +9998.0% | - | +227.3% | -35.3% | -54.1% |
| Net income growth | +44.4% | -1600.0% | +110.0% | -183.3% | +227.3% | -35.3% | - |
| Revenue CAGR (3Y) | +12.1% | -5.0% | +53.3% | -17.1% | -47.3% | -1.3% | +55.2% |
| EBITDA CAGR (3Y) | -56.1% | - | -12.6% | - | 0.0% | -27.9% | - |
| Profitability & leverage | |||||||
| Net income margin | -21.9% | -52.9% | +0.9% | -322.2% | +36.4% | +11.2% | +12.0% |
| Return on capital employed | - | 0.0% | +0.2% | 0.0% | +2.2% | +0.7% | +1.4% |
| Return on net worth | - | 0.0% | +0.2% | 0.0% | +2.2% | +0.6% | +1.4% |
| Debt / equity | - | 0.01 | 0.00 | 0.00 | 0.01 | 0.02 | 0.03 |
| Long-term debt / equity | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -200.00 | 0.00 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 3.21 | 14.71 | 2.42 | 2.71 | 4.78 | 23.67 |
| Inventory turnover | - | 0.00 | 0.00 | 40.50 | 24.75 | 5.44 | 4.44 |
| Debtors turnover | - | 0.41 | 1.73 | 4.63 | 3.14 | 3.38 | 0.88 |
| EPS (₹) | (0.24) | (0.44) | 0.02 | (2.59) | 0.36 | 0.10 | 0.17 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 8.40 | 8.84 | 8.82 | 11.41 | 11.05 | 10.96 |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Decipher Labs (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Decipher Labs
Complete news archive for Decipher Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Decipher Labs
Decipher Labs was founded in 1986.
Decipher Labs is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind Decipher Labs, Decipher Labs Limited, reported revenue of ₹14.27 Cr for FY 2026, down 38% year on year.
Decipher Labs was founded in 1986 in Hyderabad, India, as a healthcare company in the genomics sector. Genomic testing solutions are offered for patients with prostate and bladder cancer. RNA biomarkers are utilized in these tests to classify tumors and support physicians in determining treatment options. Operations focus on enabling informed decisions between patients and healthcare providers, with services centered on diagnosis and planning in the Indian market.
Decipher Labs offers Branded Formulations, ERP Implementation, and Mobile and Cloud Solutions.
Yes, Decipher Labs is publicly traded on BSE under the ticker symbol DECIPHER.
Decipher Labs operates through Decipher Labs Limited.
The legal entities of Decipher Labs currently have 7 directors, including Gayathri Raghuram, Sushant Mohan Lal, Sonam Jalan and others.